alpha-Cyano; a-Cyano-4-hydroxycinnamic acid; 2-Cyano-3-(4-hydroxyphenyl)acrylic acid; (2E)-2-cyano-3-(4-hydroxyphenyl)prop-2-enoic acid; alpha-CHCA; alpha-cyano-4-hydroxy-cinnamic acid; (E)-2-cyano-3-(4-hydroxyphenyl)acrylic acid; MFCD00004204; 1-carboxy-1-cyano-2-(4-hydroxyphenyl)ethylene; Q63391607; 4-HCCA; alpha-CCA; 2-Propenoic acid, 2-cyano-3-(4-hydroxyphenyl)-; Spectrum5_001633; 2-Cyano-3-(4-hydroxyphenyl)-2-propenoic acid; SCHEMBL26825; BSPBio_002260; MLS002207285; CHEMBL76602; (E)-2-cyano-3-(4-hydroxyphenyl)prop-2-enoic acid; BDBM4350; HMS500K21; DTXSID501018295; ZINC155109; BBL103553; CCG-39475; GEO-00838; s8612; SBB057160; STL557363; .alpha.-Cyano-4-hydroxycinnamic acid; AKOS000145566; IDI1_000219; NCGC00094622-01; NCGC00094622-02; alpha-Cyano-4-hydroxybenzenepropenoic acid; alpha-Cyano-4-hydroxycinnamic acid, 97%; alpha-Cyano-4-hydroxycinnamic acid, 99%; benzylidenemalononitrile (BMN) deriv. 34; BS-16413; SMR001306800; 2-Cyano-3-(4-hydroxyphenyl)propenoic acid; HY-107641; CS-0029043; ST50997515; A819766; (E)-2-cyano-3-(4-hydroxyphenyl)-2-propenoic acid; BRD-K60302405-001-02-9; BRD-K60302405-001-04-5; (2E)-2-Cyano-3-(4-hydroxyphenyl)-2-propenoic acid #; alpha-Cyano-4-hydroxycinnamic acid, >=98% (TLC), powder; alpha-Cyano-4-hydroxycinnamic acid, purum, >=99.0% (HPLC); alpha-Cyano-4-hydroxycinnamic acid, suitable for MALDI-TOF MS; alpha-Cyano-4-hydroxycinnamic acid, matrix substance for MALDI-MS, Ultra pure